{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:03:50Z","timestamp":1791925430740,"version":"4.3.4"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:00:00Z","timestamp":1715904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.gore.2024.101423","type":"journal-article","created":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T14:22:32Z","timestamp":1716733352000},"page":"101423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Preliminary results of adjuvant image-guided vaginal brachytherapy alone for early stage endometrial carcinoma"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3366-6146","authenticated-orcid":false,"given":"Pooriwat","family":"Muangwong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5495-1421","authenticated-orcid":false,"given":"Ekkasit","family":"Tharavichitkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somvilai","family":"Chakrabandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pitchayaponne","family":"Klunklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wimrak","family":"Onchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bongkot","family":"Jia-Mahasap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyapasara","family":"Toapichattrakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wannapha","family":"Nobnop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirut","family":"Watcharawipha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razvan M.","family":"Galalae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imjai","family":"Chitapanarux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gore.2024.101423_b0005","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.brachy.2019.02.008","article-title":"Compendium of fractionation choices for gynecologic HDR brachytherapy\u2014An American Brachytherapy Society Task Group Report","volume":"18","author":"Albuquerque","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.gore.2024.101423_b0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijrobp.2004.09.054","article-title":"Intravaginal brachytherapy alone for intermediate-risk endometrial cancer","volume":"62","author":"Alektiar","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.gore.2024.101423_b0015","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1525-1438.2008.01198.x","article-title":"Vaginal high dose rate brachytherapy alone in patients with intermediate- to high-risk stage I endometrial carcinoma after radical surgery","volume":"18","author":"Atahan","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.gore.2024.101423_b0020","doi-asserted-by":"crossref","first-page":"S322","DOI":"10.1016\/S0167-8140(15)32017-X","article-title":"EP-1899: The vaginal thickness from MRI for prescribed dose of vaginal brachytherapy in endometrial carcinoma","volume":"111","author":"Boonyawan","year":"2014","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.gore.2024.101423_b0025","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.brachy.2005.02.002","article-title":"Vaginal lymphatic channel location and its implication for intracavitary brachytherapy radiation treatment","volume":"4","author":"Choo","year":"2005","journal-title":"Brachytherapy"},{"key":"10.1016\/j.gore.2024.101423_b0030","doi-asserted-by":"crossref","unstructured":"N. Colombo, C. Creutzberg, F. Amant, T. Bosse, A. Gonz\u00e1lez-Mart\u00edn, J. Ledermann, C. Marth, R. Nout, D. Querleu, M.R. Mirza, C. Sessa, ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up, in: International Journal of Gynecological Cancer, Lippincott Williams and Wilkins, 2016: pp. 2\u201330. https:\/\/doi.org\/10.1097\/IGC.0000000000000609.","DOI":"10.1097\/IGC.0000000000000609"},{"key":"10.1016\/j.gore.2024.101423_b0035","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.gore.2024.101423_b0040","doi-asserted-by":"crossref","first-page":"655","DOI":"10.5114\/jcb.2021.112117","article-title":"Dosimetric impact of bladder filling on organs at risk with barium contrast in the small bowel for adjuvant vaginal cuff brachytherapy","volume":"13","author":"del Carmen Salas","year":"2021","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.gore.2024.101423_b0045","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijrobp.2011.12.010","article-title":"Clinical outcomes in international federation of gynecology and obstetrics stage IA endometrial cancer with myometrial invasion treated with or without postoperative vaginal brachytherapy","volume":"84","author":"Diavolitsis","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.gore.2024.101423_b0050","doi-asserted-by":"crossref","first-page":"262","DOI":"10.5114\/jcb.2014.45031","article-title":"Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer","volume":"6","author":"Eldredge-Hindy","year":"2014","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.gore.2024.101423_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14040906","article-title":"Role of Brachytherapy in the Postoperative Management of Endometrial Cancer: Decision-Making Analysis among Experienced European Radiation Oncologists","volume":"14","author":"Glatzer","year":"2022","journal-title":"Cancers (basel)"},{"key":"10.1016\/j.gore.2024.101423_b0060","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ygyno.2020.12.021","article-title":"Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations","volume":"160","author":"Hamilton","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2024.101423_b0065","first-page":"41","article-title":"Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice Guideline, Pract","volume":"13","author":"Harkenrider","year":"2023","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.gore.2024.101423_b0070","doi-asserted-by":"crossref","first-page":"526","DOI":"10.5114\/jcb.2021.110312","article-title":"A comparison between 2D and 3D planning of high-dose-rate vaginal cuff brachytherapy in patients with stage I-II endometrial cancer using cobalt-60","volume":"13","author":"Hashemi","year":"2021","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.gore.2024.101423_b0075","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.brachy.2011.12.009","article-title":"Is there any advantage to three-dimensional planning for vaginal cuff brachytherapy?","volume":"11","author":"Kim","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.gore.2024.101423_b0080","doi-asserted-by":"crossref","unstructured":"M. Koskas, F. Amant, M.R. Mirza, C.L. Creutzberg, Cancer of the corpus uteri: 2021 update, International Journal of Gynecology and Obstetrics 155 (2021) 45\u201360. https:\/\/doi.org\/10.1002\/IJGO.13866.","DOI":"10.1002\/ijgo.13866"},{"key":"10.1016\/j.gore.2024.101423_b0085","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2008.20.2424","article-title":"Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: First results of the randomized PORTEC-2 trial","volume":"27","author":"Nout","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.gore.2024.101423_b0090","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","author":"Nout","year":"2010","journal-title":"Lancet 375"},{"key":"10.1016\/j.gore.2024.101423_b0095","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.ijrobp.2011.04.014","article-title":"External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma\u2013a prospective randomized study","volume":"82","author":"Sorbe","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.gore.2024.101423_b0100","unstructured":"U.S. Department of Health and Human Service, Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0, (2017). https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_8.5x11.pdf (accessed June 16, 2019)."},{"key":"10.1016\/j.gore.2024.101423_b0105","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41416-018-0310-8","article-title":"Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy","author":"Wortman","year":"2018","journal-title":"Br J Cancer 119"},{"key":"10.1016\/j.gore.2024.101423_b0110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ygyno.2018.07.020","article-title":"Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: Evaluation of the pilot phase of the PORTEC-4a trial","author":"Wortman","year":"2018","journal-title":"Gynecol Oncol 151"},{"key":"10.1016\/j.gore.2024.101423_b0115","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.radonc.2020.10.038","article-title":"Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer","volume":"155","author":"Wortman","year":"2021","journal-title":"Radiother. Oncol."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578924001024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578924001024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T07:44:31Z","timestamp":1722239071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578924001024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":23,"alternative-id":["S2352578924001024"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2024.101423","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preliminary results of adjuvant image-guided vaginal brachytherapy alone for early stage endometrial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2024.101423","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101423"}}